Our genetic research allows us to produce bespoke strains with specific agronomic and pharmaceutical traits. Our molecular breeding platform enables us to quickly identify and incorporate commercially valuable traits of cannabis plants to create new, stable cannabis lines. This molecular breeding platform dramatically reduces our development time for new high-value varieties of cannabis.
These strains can be purchased from Blossom for cultivation or life science purposes.
Our EU-GMP facilities produce pharmaceutical grade medical cannabis products. Our licenses allow us to operate a full “genetics to plant” breeding model meaning we not only analyse germplasm but the mature crop on a commercial scale providing insights from data at a large scale.
We control the entire supply chain to ensure our customers receive nothing but the highest quality products.
Our products are used by the pharmaceutical industry. We supply our genetics to medical cultivators or drug developers. Compliance and ethics are our two fundamental policies. This stands us apart from a lot of medical cannabis businesses and makes us the supplier of choice for the medical industry.
Our research covers cultivation, genetics and product development. We consider scientific research essential to further cannabis use in modern medicine.
We Integrate With Your Ecosystem
Blossom delivers premium cannabis genetics, plants & technical support to growers worldwide. All our private genetics must achieve two fundamental goals: grower profitability and market differentiation.
Our teams of PhD breeders and technical staff along with our partners work to drive the science. Our breeding processes marry the disciplined science of crossing, evaluating, trialing, and selecting at sites around the globe.
To learn more about Blossom strains and products that are suitable for you please contact us.